back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-01-31 15:30 Tx date 2024-01-29 |
$ZYUS
ZYUS Life Sciences Corporation |
Zettl, Brenton Harold
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$169,280
+184,000 vol $0.92 each |
184,000 | |
| Filed 2024-01-31 15:29 Tx date 2023-06-09 |
$ZYUS
ZYUS Life Sciences Corporation |
Zettl, Brenton Harold
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-06-16 16:35 Tx date 2023-06-09 |
$ZYUS
ZYUS Life Sciences Corporation |
Zettl, Brenton Harold
6 - Director or Senior Officer of 10% Security Holder
Holder: 102042227 Saskatchewan Ltd. (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
1,208,704 | ||
| Filed 2023-06-16 16:14 Tx date 2023-06-09 |
$ZYUS
ZYUS Life Sciences Corporation |
Zettl, Brenton Harold
6 - Director or Senior Officer of 10% Security Holder
Holder: 1189115 B.C. Ltd. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
660,413 | ||
| Filed 2023-06-16 16:13 Tx date 2023-06-09 |
$ZYUS
ZYUS Life Sciences Corporation |
Zettl, Brenton Harold
6 - Director or Senior Officer of 10% Security Holder
Holder: 102042227 Saskatchewan Ltd. (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-06-16 14:06 Tx date 2023-06-09 |
$ZYUS
ZYUS Life Sciences Corporation |
Zettl, Brenton Harold
6 - Director or Senior Officer of 10% Security Holder
Holder: 102042227 Saskatchewan Ltd. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
33,724,072 | ||
| Filed 2023-06-16 14:02 Tx date 2023-06-09 |
$ZYUS
ZYUS Life Sciences Corporation |
Zettl, Brenton Harold
6 - Director or Senior Officer of 10% Security Holder
Holder: Brent Zettl, In Trust for Stephen Zettl (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
14,088 | ||
| Filed 2023-06-16 13:39 Tx date 2023-06-09 |
$ZYUS
ZYUS Life Sciences Corporation |
Zettl, Brenton Harold
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
493,108 | ||
| Filed 2018-03-26 Tx date 2018-03-24 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-2,130,940 vol |
0 | |
| Filed 2018-02-21 Tx date 2018-02-07 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,891,375
-125,000 vol $31.13 each |
2,242,640 | |
| Filed 2018-02-21 Tx date 2018-02-09 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,573,596.63
-73,700 vol $34.92 each |
2,130,940 | |
| Filed 2018-02-21 Tx date 2018-02-09 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,440,393.80
-38,000 vol $37.91 each |
||
| Filed 2018-02-21 Tx date 2018-02-08 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,891,375
-125,000 vol $31.13 each |
||
| Filed 2018-02-21 Tx date 2018-02-07 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,440,393.80
-38,000 vol $37.91 each |
2,204,640 | |
| Filed 2018-02-20 Tx date 2017-11-29 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$187,300
+40,000 vol $4.68 each |
2,367,640 | |
| Filed 2018-01-25 Tx date 2017-11-29 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-187,300
-40,000 vol $4.68 each |
0 | |
| Filed 2018-01-25 Tx date 2017-11-29 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$187,300
+40,000 vol $4.68 each |
||
| Filed 2018-01-25 Tx date 2017-11-29 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$187,300
+40,000 vol $4.68 each |
||
| Filed 2018-01-25 Tx date 2017-01-25 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+16,736 vol |
923,140 | |
| Filed 2017-12-11 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-12-11 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-12-11 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
906,404 | ||
| Filed 2017-12-11 Tx date 2017-01-25 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
36 - Conversion or exchange
|
$
+$16,736 vol $5.50 each |
||
| Filed 2017-12-11 Tx date 2017-01-25 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
36 - Conversion or exchange
|
$
+$16,736 vol $4.60 each |
||
| Filed 2017-12-11 Tx date 2017-01-25 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
36 - Conversion or exchange
|
-$92,060 vol |
$0 | |
| Filed 2017-11-29 Tx date 2017-11-24 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-67,300
-40,000 vol $1.68 each |
440,000 | |
| Filed 2017-11-29 Tx date 2017-11-24 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-673,000
-400,000 vol $1.68 each |
40,000 | |
| Filed 2017-11-29 Tx date 2017-11-28 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-273,000
-400,000 vol $0.68 each |
||
| Filed 2017-11-29 Tx date 2017-11-24 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-497,500
-500,000 vol $0.99 each |
480,000 | |
| Filed 2017-11-29 Tx date 2017-11-24 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-273,000
-400,000 vol $0.68 each |
980,000 | |
| Filed 2017-11-29 Tx date 2017-11-24 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$673,000
+400,000 vol $1.68 each |
2,310,904 | |
| Filed 2017-11-29 Tx date 2017-11-24 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$67,300
+40,000 vol $1.68 each |
1,910,904 | |
| Filed 2017-11-29 Tx date 2017-11-24 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$497,500
+500,000 vol $0.99 each |
1,870,904 | |
| Filed 2017-11-29 Tx date 2017-11-24 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$273,000
+400,000 vol $0.68 each |
1,370,904 | |
| Filed 2017-06-30 Tx date 2017-06-28 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$58,312
+7,300 vol $7.99 each |
970,904 | |
| Filed 2017-06-30 Tx date 2017-06-28 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$58,312
+7,300 vol $7.99 each |
||
| Filed 2017-06-30 Tx date 2017-06-27 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$57,600
+7,200 vol $8.00 each |
963,604 | |
| Filed 2017-06-30 Tx date 2017-06-27 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$58,312
+7,300 vol $7.99 each |
||
| Filed 2017-06-29 Tx date 2017-06-28 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$58,312
+7,300 vol $7.99 each |
963,704 | |
| Filed 2017-06-29 Tx date 2017-06-27 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$58,312
+7,300 vol $7.99 each |
||
| Filed 2017-06-28 Tx date 2017-06-27 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$28,800
+3,600 vol $8.00 each |
||
| Filed 2017-06-28 Tx date 2017-06-27 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$28,800
+3,600 vol $8.00 each |
||
| Filed 2017-06-16 Tx date 2017-06-15 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$395,500
+50,000 vol $7.91 each |
956,404 | |
| Filed 2017-02-02 Tx date 2017-01-25 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
36 - Conversion or exchange
|
$
+$16,736 vol $4.60 each |
$108,796 | |
| Filed 2017-02-02 Tx date 2017-01-25 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
36 - Conversion or exchange
|
$
+$16,736 vol $5.50 each |
||
| Filed 2016-12-29 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
$92,060 | ||
| Filed 2016-12-29 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
1,380,000 | ||
| Filed 2016-12-29 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
906,404 |